Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is a morbid complication following acute pulmonary embolism (PE). The optimal treatment to prevent this sequela remains unknown. We aimed to compare the biomarker profile and short-term functional outcomes in patients who received catheter-directed thrombolysis (CDT) versus anticoagulation alone.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Vascular Surgery: Venous and Lymphatic Disorders
Paper Title
Journal
Date
